Alger logo

Alger

North America, New York, United States, New York

Description

Fred Alger Management is an asset management arm of Fred Alger & Company Incorporated.

Investor Profile

Alger has made 8 investments, with 2 in the past 12 months and 50% as lead.

Stage Focus

  • Series Unknown (38%)
  • Post Ipo Debt (13%)
  • Series B (13%)
  • Series D (13%)
  • Post Ipo Equity (13%)
  • Series E (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Hospital
  • Life Science
  • Health Diagnostics
  • Personal Health
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alger frequently co-invest with?

Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Kennedy Lewis Investment Management
North America, New York, United States, New York
Co-Investments: 1
Squarepoint Capital
North America, New York, United States, New York
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
Tybourne Capital Management
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Co-Investments: 1
Abiomed
North America, Massachusetts, United States, Danvers
Co-Investments: 1

Which angels does Alger often collaborate with?

SK
Europe, England, United Kingdom, London
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 1
David Siegel
North America, New York, United States, White Plains
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 1
SN
North America, Florida, United States, Miami
Shared Deals: 1
YL
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Alger?

SandboxAQ

Palo Alto, California, United States

SandboxAQ develops AI and quantum technology solutions that enhances cybersecurity and materials science.

Artificial Intelligence (AI)Cyber SecurityInformation TechnologyQuantum ComputingSaaS
Series EDec 18, 2024
Amount Raised: $300,000,000
Forte Biosciences

Sherman Oaks, California, United States

Forte Biosciences is a biotechnology company that focuses on dermatology.

BiotechnologyHealth CareLife SciencePharmaceutical
Post Ipo EquityNov 20, 2024
Amount Raised: $53,000,000
Impulse Dynamics

Marlton, New Jersey, United States

Impulse Dynamics is a medical device company offering innovative solutions for the treatment of chronic heart failure.

BiotechnologyHospitalMedicalMedical Device
Series UnknownFeb 14, 2024
Amount Raised: $136,000,000
Forte Biosciences

Sherman Oaks, California, United States

Forte Biosciences is a biotechnology company that focuses on dermatology.

BiotechnologyHealth CareLife SciencePharmaceutical
Post Ipo DebtAug 1, 2023
Amount Raised: $25,000,000
Impulse Dynamics

Marlton, New Jersey, United States

Impulse Dynamics is a medical device company offering innovative solutions for the treatment of chronic heart failure.

BiotechnologyHospitalMedicalMedical Device
Series UnknownMay 12, 2022
Amount Raised: $101,000,000
Prosetta Biosciences

San Francisco, California, United States

Prosetta Biosciences is a San Francisco based biotech focused on novel antiviral research.

BiotechnologyHealth CareMedical
Series DDec 3, 2015
Amount Raised: $31,000,000
Tolero Pharmaceuticals

Salt Lake City, Utah, United States

Tolero Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics to treat cancer and other life-threatening diseases.

BiotechnologyHealth CarePharmaceutical
Series BAug 7, 2014
Amount Raised: $14,200,000
Intarcia Therapeutics

Hayward, California, United States

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

BiotechnologyHealth CareHealth DiagnosticsMedical DevicePersonal Health
Series UnknownApr 1, 2014
Amount Raised: $200,000,000